News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
289–324
Matches
25927
Sources here
26
Companies here
37
Search results Stored financial headlines

Active search

25927 matching headlines

Ticker or company: XMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Baxter hires new CFO with visa contingency

Baxter International has named John Rogers, formerly CFO of Smith+Nephew and WPP, as its new CFO, with his start date of October 1 contingent on him securing the necessary U.S. visa and work permits. If the visa isn't obtained by then, he will temporarily …

BAX main company
Sharemaestro market context Trend signal active 52 weeks +9.8% BAX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quanex Building Products Announces Third Quarter 2026 Earnings Release and Conference Call Schedule

Quanex Building Products Corporation announced it will release its third-quarter 2026 financial results on Thursday, September 3, 2026, after the New York Stock Exchange closes. A conference call to discuss these results is scheduled for Friday, September 4, 2026, at 11:00 a.m. ET. Details …

NX main company
Sharemaestro market context Price above Trend Line 52 weeks -4.9% NX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

American Express Declares Dividend on Series E Preferred Shares

NEW YORK, August 20, 2026--(BUSINESS WIRE)--The Board of Directors of American Express Company (NYSE: AXP) declared a dividend on the company's 6.450% Fixed Rate Reset Noncumulative Preferred Shares, Series E, of $5,912.50 per share (which is equivalent to $5.91250 per related Depositary Share). The …

AXP main company AXP main company AXPB34 main company AXP main company AEC1 main company AXP main company
Sharemaestro market context Trend signal started 52 weeks -1.6% · Next-week setup positive 57.8% AXP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Texas Capital Bancshares (TCBI) insider makes 51-share stock gift

Texas Capital Bancshares (TCBI) Chief Legal Officer Anna M. Alvarado reported a bona fide gift transfer of 51 shares of common stock on August 19, 2026. Following this transaction, her direct holdings stand at 23,759 shares. The transfer was classified as a gift with …

TCBI main company
Sharemaestro market context Trend signal active 52 weeks +15.7% TCBI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Federal Court Grants Motion to Stay Proceedings in Scilex v. Wade et al.

A federal court has granted a motion to compel arbitration and stay all court proceedings in California for the case of Scilex Holding Company v. Wade et al. The court found a valid and enforceable arbitration clause in the Loan Agreement between Scilex and …

SCLX main company
Sharemaestro market context Trend signal active 52 weeks -42.5% · Next-week setup negative 43.9% SCLX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Flux Power Q4 Revenue Reaches $8.2 Million as Net Loss Narrows Sequentially

Flux Power (FLUX) reported fiscal fourth-quarter revenue of $8.248 million, an increase from the previous quarter, while its GAAP net loss sequentially narrowed to $2.312 million. For the full fiscal year 2026, revenue was $42.132 million with a net loss of $7.448 million. The …

FLUX main company
Sharemaestro market context Price below Trend Line 52 weeks -66.6% · Next-week setup negative 39.4% FLUX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Axos Financial FY 2026: Revenue $1.957B, EPS $8.48— 10-K Summary

Axos Financial, Inc. reported a strong financial year in 2026, with revenue reaching $1.957 billion and diluted earnings per share at $8.48. This growth was primarily driven by significant loan growth and increased loan yields, along with strategic expansions in their deposit base and …

AX main company
Sharemaestro market context Trend signal active 52 weeks +12.6% AX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Battery maker Flux Power posts $42.1M in yearly sales and a $7.4M loss

Flux Power (NASDAQ: FLUX) reported fiscal year 2026 revenue of $42.1 million, a decrease from $66.4 million in 2025, and a net loss of $7.4 million. Despite a sequential increase in Q4 revenue to $8.2 million, the company experienced a year-over-year decline in both …

FLUX main company
Sharemaestro market context Price below Trend Line 52 weeks -66.6% · Next-week setup negative 39.4% FLUX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Flux Power Reports 2026 Fiscal Fourth Quarter and Full Year Financial Results

Flux Power Holdings, Inc. announced its financial and operational results for the 2026 fiscal fourth quarter and full fiscal year, ending June 30, 2026. The company reported fourth-quarter revenue of $8.2 million and full-year revenue of $62.1 million. Notable highlights include a 33% decrease …

FLUX main company
Sharemaestro market context Price below Trend Line 52 weeks -66.6% · Next-week setup negative 39.4% FLUX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ultragenyx scores FDA approval for gene therapy made at Bedford facility

Ultragenyx has received FDA approval for a new gene therapy that targets the root cause of glycogen storage disease type Ia. The therapy is manufactured at the company's facilities in Bedford, Massachusetts. Ultragenyx has a significant operational presence in Bedford, Somerville, and Woburn.

RARE main company
Sharemaestro market context Trend signal active 52 weeks -11.0% RARE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Veraxa Biotech (VRXA) interim CFO discloses zero share ownership

Veraxa Biotech Holding AG's interim CFO, Carl von Halem, filed a Form 3 indicating no beneficial ownership of VRXA securities. This initial statement shows no equity transactions or holdings and no Rule 10b5-1 trading plan. The filing suggests a neutral impact and sentiment regarding …

VRXA main company
Sharemaestro market context Stored weekly price path 10 weeks -90.6% · Next-week setup negative 26.5% VRXA stored weekly price path from 12 Jun 2026 to 14 Aug 2026

Anterix (ATEX) director donates 5,400 shares in gift

Anterix Inc. director William Heard reported a bona fide gift of 5,400 shares of Common Stock on August 19, 2026, to a Donor Advised Fund. Following this charitable donation, Heard directly holds 3,965 shares and indirectly holds 1,670,338 shares through investment funds managed by …

ATEX main company
Sharemaestro market context Trend signal active 52 weeks +307.7% ATEX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Texas Pacific Land Jumps 5.5% Amid Sector-Wide Rally

Texas Pacific Land Corporation (TPL) surged 5.5% to close at $393.60, driven by a broad sector-wide rally in energy-related equities. The company's gains were mirrored by peers, indicating a broader market repositioning or sector rotation rather than company-specific news. TPL, operating in oil and …

TPL main company
Sharemaestro market context Price below Trend Line 52 weeks +18.7% TPL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Intercontinental Exchange (NYSE: ICE) taps bonds to finance planned MarketAxess acquisition

Intercontinental Exchange (ICE) has raised approximately $3.71 billion in net proceeds through a multi-tranche public debt offering, issuing senior notes with maturities ranging from 2029 to 2036. These funds, along with other financing sources, are intended to finance the acquisition of MarketAxess Holdings Inc. …

ICE main company
Sharemaestro market context Price above Trend Line 52 weeks -13.3% ICE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Extra Space Storage stock holds firm as dividend and guidance support outlook

Extra Space Storage (EXR) stock is trading near its consensus target after confirming a third-quarter 2026 dividend of $1.62 per share and reiterating higher core FFO guidance. This provides investors with clear visibility on cash flows and balance sheet strength, with the stock currently …

EXR main company
Sharemaestro market context Trend signal active 52 weeks +8.5% EXR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pixelworks (PXLW) CEO offloads shares to pay RSU tax bill

Pixelworks (PXLW) President and CEO Todd Debonis sold 7,917 shares of common stock on August 18, 2026, at $6.7357 per share. This transaction was conducted to cover the tax obligations arising from restricted stock units that vested on August 14, 2026. Following the sale, …

PXLW main company
Sharemaestro market context New activity signal 52 weeks -16.4% · Next-week setup negative 41.8% PXLW stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Virginia SCC to hold public hearing on NextEra Energy transmission line

The Virginia State Corporation Commission (SCC) will hold a public hearing in September regarding NextEra Energy Transmission Virginia Inc.'s request to build a 107.5-mile electric transmission line, the Mid-Atlantic Resiliency Link, in Frederick County. SCC Commissioner Kelsey Bagot, a former NextEra Energy attorney, has …

NEE main company
Sharemaestro market context Price below Trend Line 52 weeks +16.2% · Next-week setup positive 55.1% NEE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ECARX (ECX) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 11, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Founder and Chief Executive Officer - Ziyu Shen Chief Operating Officer - Peter Cirino Chief Financial Officer - Dylan Jeng Full Conference Call Transcript Operator: Good day, and …

ECX main company
Sharemaestro market context Price below Trend Line 52 weeks -35.9% ECX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SpaceX stock falls back to below IPO price

[Headquarters of SpaceX in Hawthorne, California] Sven Piper/iStock Editorial via Getty Images SpaceX (SPCX [https://seekingalpha.com/symbol/SPCX]) shares dropped nearly 5% on Thursday to $132.69 apiece, slipping back below their $135 initial public offering price and breaking a streak of six consecutive closes above that key …

SPCX main company
Sharemaestro market context Stored weekly price path 10 weeks -13.0% · Next-week setup negative 35.2% SPCX stored weekly price path from 12 Jun 2026 to 14 Aug 2026

TJX Companies Inc Stock (TJX) Moved Down by 3.07% on Aug 20: What Investors Need To Know

TJX Companies Inc. (TJX) saw its stock drop by 3.07% on August 20, 2026, following the release of its Q2 fiscal 2027 financial results. Despite beating revenue and EPS expectations, the stock declined due to execution issues within its Marmaxx division and concerns over …

TJX main company
Sharemaestro market context Trend signal ended 52 weeks +12.4% · Next-week setup positive 61.9% TJX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

RTX Corp Stock (RTX) Moved Down by 3.28% on Aug 20: What Investors Need To Know

RTX Corp (RTX) stock dropped 3.28% due to short-term profit-taking after a strong rally, coupled with insider equity sales and high valuation premiums. Despite the decline, the company's core operational trajectory is supported by strong commercial aerospace demand and military replenishment orders. Technical indicators …

RTX main company
Sharemaestro market context Trend signal started 52 weeks +44.4% · Next-week setup positive 57.2% RTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ultragenyx Gene Therapy Becomes First FDA-Approved Treatment for Ultra-Rare Disease

Ultragenyx Pharmaceutical's gene therapy, Genglycos, has received accelerated FDA approval as the first treatment for glycogen storage disease type Ia (GSDIa). This one-time treatment addresses the root cause of the ultra-rare inherited enzyme deficiency, which previously required patients to consume raw cornstarch frequently. The …

RARE main company
Sharemaestro market context Trend signal active 52 weeks -11.0% RARE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citigroup Raises Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target to $58.00

Citigroup has raised its price target for Ultragenyx Pharmaceutical (NASDAQ:RARE) to $58.00 from $45.00, maintaining a "buy" rating and suggesting a nearly 129% upside. This follows positive sentiment around the FDA approval of GENGLYCOS, Ultragenyx’s fifth approved product, which analysts believe will create significant …

RARE main company
Sharemaestro market context Trend signal active 52 weeks -11.0% RARE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context